PMA P030052S009

Device
UROVYSION BLADDER CANCER KIT ASSAY
Applicant
Abbott Molecular
PMA number
P030052
Supplement
S009
Product code
NSD
Decision date
2012-08-10
Classification
Test, Fluorescence In Situ Hybridization (fish), For Bladder Cancer Detection And Monitoring For Recurrence
Generic name
Test, fluorescence in situ hybridization (fish), for bladder cancer detection and monitoring for recurrence
Approval order statement
ELIMINATE A SECOND CLONE IDENTITY TESTING PROCEDURE AT THE FERMENTATION STAGE FOR LSI 9P21, QUALIFY THE GENEPREP INSTRUMENT, QUALIFY THE OVERHEADMIXING SYSTEM AND VALIDATION OF MIXING PROCESS IN THE MANUFACTURE OF HYBRIDIZATION BUFFER,IMPLEMENT THE OPTICAL DENSITY READING AS AN ADDITIONAL IN PROCESS QUALITY CONTROL, VALIDATE ANEXISTING MIXING PROCESS FOR THE UROVYSION BULK SOLUTION, AND TRANSFER AN EXISTING IN-PROCESS TESTING OF LABELED DNA.

Current openFDA PMA Record#

Device
UROVYSION BLADDER CANCER KIT ASSAY
Applicant
Abbott Molecular
PMA number
P030052
Supplement
S009
Product code
NSD
Generic name
Test, fluorescence in situ hybridization (fish), for bladder cancer detection and monitoring for recurrence
Decision date
2012-08-10
Decision code
OK30
Date received
2012-07-13
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
ELIMINATE A SECOND CLONE IDENTITY TESTING PROCEDURE AT THE FERMENTATION STAGE FOR LSI 9P21, QUALIFY THE GENEPREP INSTRUMENT, QUALIFY THE OVERHEADMIXING SYSTEM AND VALIDATION OF MIXING PROCESS IN THE MANUFACTURE OF HYBRIDIZATION BUFFER,IMPLEMENT THE OPTICAL DENSITY READING AS AN ADDITIONAL IN PROCESS QUALITY CONTROL, VALIDATE ANEXISTING MIXING PROCESS FOR THE UROVYSION BULK SOLUTION, AND TRANSFER AN EXISTING IN-PROCESS TESTING OF LABELED DNA.